Ex vivo studies of K+ channel activity in CD8+ T lymphocytes of HNSCC patients treated with anti-PD-1 blocking antibodies also showed an increase in KCa3.1 and Kv1.3 activities [87]. This evidence concerns the gene CD8A and head and neck squamous cell carcinoma.